Page last updated: 2024-10-31

methyl salicylate and Leishmaniasis, Cutaneous

methyl salicylate has been researched along with Leishmaniasis, Cutaneous in 1 studies

methyl salicylate: used in over-the-counter liniments, ointments, lotions for relief of musculoskeletal aches and pains; has hemolytic effect on human & sheep erythrocytes; RN given refers to parent cpd; structure in Merck Index, 9th ed, #5990
methyl salicylate : A benzoate ester that is the methyl ester of salicylic acid.

Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahashi, M1
Fuchino, H1
Sekita, S1
Satake, M1

Other Studies

1 other study available for methyl salicylate and Leishmaniasis, Cutaneous

ArticleYear
In vitro leishmanicidal activity of some scarce natural products.
    Phytotherapy research : PTR, 2004, Volume: 18, Issue:7

    Topics: Animals; Antiprotozoal Agents; Betula; Ferns; Inhibitory Concentration 50; Leishmania major; Leishma

2004